Palonosetron (Aloxi): A Second-Generation 5-Ht3 Receptor Antagonist for Chemotherapy-Induced Nausea and Vomiting

Baylor University Medical Center Proceedings - United States
doi 10.1080/08998280.2006.11928210
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Informa UK Limited

Related search

Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting: Approval and Efficacy

Cancer Management and Research
Oncology
2009English

Real-World Effectiveness of Palonosetron-Based Antiemetic Regimens: Preventing Chemotherapy-Induced Nausea and Vomiting

Journal of Comparative Effectiveness Research
Health Policy
2019English

Effects of Vagotomy and 5-Ht3 Antagonist for Drug Inductivity Vomiting.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1993English

5-Ht3 Receptor Antagonism by Anpirtoline, a Mixed 5-Ht1 Receptor Agonist/5-Ht3 Receptor Antagonist

British Journal of Pharmacology
Pharmacology
1995English

Evolving Role of Neurokinin 1-Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting

OncoTargets and Therapy
OncologyPharmacology
2018English

Efficacy of Triple Antiemetic Therapy (Palonosetron, Dexamethasone, Aprepitant) for Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Carboplatin-Based, Moderately Emetogenic Chemotherapy.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2016English

Preventing Chemotherapy-Induced Nausea and Vomiting With Netupitant/Palonosetron, the First Fixed Combination Antiemetic: Current and Future Perspective

Future Oncology
MedicineCancer ResearchOncology
2019English

Dronabinol for Chemotherapy-Induced Nausea and Vomiting Unresponsive to Antiemetics

Cancer Management and Research
Oncology
2016English

Palonosetron Exhibits Higher Total Control Rate Compared to First-Generation Serotonin Antagonists and Improves Appetite in Delayed-Phase Chemotherapy-Induced Nausea and Vomiting

Molecular and Clinical Oncology
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy